A Better Future for Patients with Restless Legs Syndrome

American Journal of Medicine

Volumn 120, Issue 1 SUPPL. 1, 2007, Pages

  Winkelman, John W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Dopaminergic agonists; Gabapentin; Pramipexole; Restless legs syndrome; Ropinirole

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; IRON;

ARTICLE; CLINICAL TRIAL; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SUPPLEMENTATION; TREATMENT OUTCOME;

CLINICAL TRIALS; HUMANS; PRACTICE GUIDELINES; RESTLESS LEGS SYNDROME;

EID: 33845783866     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.11.005     Document Type: Article

References (5)

1. Earley C.J. Restless legs syndrome. N Engl J Med 348 (2003) 2103-2109
2. Allen R.P., Picchietti D., Hening W.A., et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health. Sleep Med 4 (2003) 101-119
3. Hening W.A., Allen R.P., Earley C.J., et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 (2004) 560-583
4. Earley C.J., Heckler D., and Allen R.P. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 5 (2004) 231-235
5. Sloand J.A., Shelly M.A., Feigin A., Bernstein P., and Monk R.D. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 43 (2004) 663-670